The Scary Side of Synagis

by Sarah Pope MGA Affiliate linksHealthy Pregnancy, Baby & Child, VaccinationComments: 172

rsv therapy synagis shot dangers
In recent months, doctors have upped the ante and are pushing hard for all babies born at less than 35 weeks gestation to receive periodic shots of the drug Palivizumab, more popularly known as Synagis, in order to lessen the severity of Respiratory Syncytial Virus (RSV).  RSV is usually a mild respiratory illness but can prove severe and even fatal under certain situations for premature babies.

“Don’t worry, Synagis isn’t a vaccine. It will simply help protect your baby’s growing lungs”  is the typical response from doctors when parents question the need for the treatment and whether or not it is truly safe.

What to do? Is RSV Therapy using Synagis injections safe for your baby?

Just Because Synagis is Not a Vaccine Doesn’t Mean It’s Safe

Synagis is not technically a vaccine. It is an immunoglobulin that must be administered in 5 separate injections usually into the thigh muscle at the whopping cost of $1300-2600 per injection. (1)

It is important to note that Synagis does not prevent RSV infection and only potentially reduces the severity of illness should RSV be contracted.  

Synagis Ingredients

The ingredients list for injected Synagis has nowhere near the level of chemical toxicity of a childhood vaccine. Thimerosal and aluminum adjuvants are not used in the manufacture of Synagis.

Each single dose vial of Synagis contains: (2)

  • Palivizumab (active ingredient)
  • Glycine (amino acid, stabilizing agent)
  • Histidine (amino acid, stabilizing agent)
  • Mannitol (bulking agent)

Synagis Side Effects

Published side effects of Synagis include: (3)

  • high fever, ear pain or drainage, tugging at the ear
  • warmth or swelling of the ear
  • crying or fussiness, especially while lying down
  • change in sleeping patterns
  • poor feeding or loss of appetite
  • easy bruising or bleeding

The Dark Side of Synagis No One is Talking About

The scary side of Synagis is that the manufacturing of this immunoglobulin uses recombinant DNA (rDNA) technology.

What this means is that an artificial antibody that exists nowhere in nature was created using a composite of 95% human and 5% rodent (murine) antibody sequences in a process that involves the grafting of the rat antibody into the human antibody framework. (4)

I personally find this type of technology incredibly disturbing.  Injecting artificial, genetically modified antibodies that contain rat DNA into a human baby that is growing and developing has completely unforeseen and possibly disastrous long term consequences not only for that child but also for future generations.

Doctors are irresponsible and downright immoral for not informing their patients of exactly what Synagis truly is before injecting it into these helpless babies who are in fact nothing but guinea pigs sacrificed on the altar of bioengineering.

rDNA technology is the same genetic engineering process used to produce GM rice (called Golden Rice) which is artificially high in beta carotene. GM rice is not currently on the market due to ongoing disputes pertaining to the intellectual property and environmental issues of this recombinant product.

Guess what else was produced using rDNA technology?

GM corn! Genetically modified corn contains a recombinant form of Bacillus thuringeiensis (Bt), a bacterium with potent insecticidal properties. In essence, Bt corn plants produce their own insecticide so when you eat it or any food containing it, you are ingesting pesticides that can’t and won’t wash off.

Ingestion of genetically modified Bt corn has been associated with organ failure in animals. (5)

The effect on humans is still speculative but given the ominous effect on animals, is very likely health damaging.

Your Best Bet? Skip Synagis

If you prefer your child not to be part of some gruesome genetic experiment that generously lines the pocket of your doctor and his pharmaceutical rep, then just say no to Synagis. It doesn’t prevent RSV anyway and the reduction in severity of symptoms should your child contract the illness is debatable.

No doubt, the high cost and generous profit margin of Synagis play a big role in the aggressive marketing in doctor’s offices to the emotionally vulnerable parents of premature babies.

Best to implement the tried and true methods for illness prevention for your baby during RSV season which include good handwashing habits, regular laundering of blankets and toys with a nontoxic and unscented detergent, and limiting exposure to crowds during cold and flu season.  In addition, never ever allow smoking around your baby or in the location where the baby is residing.

More rDNA Treatments on the Horizon

Even savvy parents already aware of the dangers of Synagis need to keep their guard up and remain on alert.

The success and handsome profits generated by artificially manufactured DNA treatments like Synagis are easy to slip under a protective parent’s radar. This is because they aren’t technically vaccines. This virtually guarantees the development of even more rDNA treatments in the future.

Big Pharma will no doubt accelerate its efforts using rDNA in the coming years to capitalize on a generation of increasingly sickly and “genetically challenged” children.

References

(1) Cost of RSV Therapy

(2) Synagis Ingredients List

(3, 4) Synagis Data Sheet, human/rodent antibody ingredients (generic name palivizumab)

(5) Bt Corn linked to organ failure in animals

Sarah Pope has been a Health and Nutrition Educator since 2002. She serves on the Board of Directors for the Weston A. Price Foundation.

Sarah was awarded Activist of the Year at the International Wise Traditions Conference in 2010.

Sarah earned a Bachelor of Arts (summa cum laude, Phi Beta Kappa) in Economics from Furman University and a Master’s degree in Government (Financial Management) from the University of Pennsylvania.

Mother to three healthy children, blogger, and best-selling author, she writes about the practical application of Traditional Diet and evidence-based wellness within the modern household. Her work has been featured by USA Today, The New York Times, National Review, ABC, NBC, and many others.

Comments (172)

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Pin It on Pinterest

    Share This